Author:
Luck Maria I.,Subillaga Erick J.,Borenstein Ronen,Sabo Yosef
Abstract
AbstractThe human respiratory syncytial virus (hRSV) and the human metapneumovirus (hMPV) are important human respiratory pathogens from the Pneumoviridae family. Both are responsible for severe respiratory tract infections in infants, young children, elderly individuals, adults with chronic medical conditions, and immunocompromised patients. Despite their large impact on human health, vaccines for hRSV were only recently introduced, and only limited treatment options exist. Here we show that Ginkgolic acid (GA), a natural compound from the extract of Ginkgo biloba, with known antiviral properties for several viruses, efficiently inhibits these viruses’ infectivity and spread in cultures in a dose-dependent manner. We demonstrate that the drug specifically affects the entry step during the early stages on the viruses’ life cycle with no effect on post-entry and late stage events, including viral gene transcription, genome replication, assembly and particles release. We provide evidence that GA acts as an efficient antiviral for members of the Pneumoviridae family and has the potential to be used to treat acute infections.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Rima, B. et al. ICTV virus taxonomy profile: Pneumoviridae. J. Gen. Virol. 98(12), 2912–2913 (2017).
2. Glezen, W. P. et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140(6), 543–546 (1986).
3. Falsey, A. R. et al. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352(17), 1749–1759 (2005).
4. Panda, S. et al. Human metapneumovirus: Review of an important respiratory pathogen. Int. J. Infect. Dis. 25, 45–52 (2014).
5. Davis, C. R. et al. Incidence, morbidity, and costs of human metapneumovirus infection in hospitalized children. J. Pediatric. Infect. Dis. Soc. 5(3), 303–311 (2016).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献